Back to Journals » Neuropsychiatric Disease and Treatment » Volume 4

Neuropsychiatric Disease and Treatment

ISSN: 1178-2021


Archive: Volume 4, 2008


Erratum

Shapiro MA, Chang YL, Munson SK, et al.

Neuropsychiatric Disease and Treatment 2008, 4:319-319

Published Date: 8 February 2008

First true initial ictal SPECT in partial epilepsy verified by electroencephalography

Jesús Pastor, Luis Domínguez-Gadea, Rafael G Sola, Virgilio Hernando, María Luisa Meilán, et al

Neuropsychiatric Disease and Treatment 2008, 4:305-309

Published Date: 8 February 2008

Effects of milnacipran on binge eating – a pilot study

Shun’ichi Noma, Teruhisa Uwatoko, Haruka Yamamoto, Takuji Hayashi

Neuropsychiatric Disease and Treatment 2008, 4:295-300

Published Date: 8 February 2008

White versus gray matter function as seen on neuropsychological testing following bone marrow transplant for acute leukemia in childhood

Fiona S Anderson, Alicia S Kunin-Batson, Joanna L Perkins, K Scott Baker

Neuropsychiatric Disease and Treatment 2008, 4:283-288

Published Date: 8 February 2008

Preliminary effects of pagoclone, a partial GABAA agonist, on neuropsychological performance

Angela F Caveney, Bruno Giordani, George M Haig

Neuropsychiatric Disease and Treatment 2008, 4:277-282

Published Date: 8 February 2008

Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

André Tadic, Dan Rujescu, Matthias J Müller, Ralf Kohnen, Hans H. Stassen, et al

Neuropsychiatric Disease and Treatment 2008, 4:269-276

Published Date: 8 February 2008

Prevalence of eating disorders and eating attacks in narcolepsy

Norbert Dahmen, Julia Becht, Alice Engel, Monika Thommes, Peter Tonn

Neuropsychiatric Disease and Treatment 2008, 4:257-261

Published Date: 8 February 2008

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?

Maurizio Pompili, Marco Innamorati, Michele Raja, Ilaria Falcone, Giuseppe Ducci, et al

Neuropsychiatric Disease and Treatment 2008, 4:247-255

Published Date: 8 February 2008

Functional MRI evidence for language plasticity in adult epileptic patients: Preliminary results

Emilie Cousin, Monica Baciu, Cédric Pichat1, Philippe Kahane, Jean-François Le Bas

Neuropsychiatric Disease and Treatment 2008, 4:235-246

Published Date: 8 February 2008

Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran

Naghmeh Mokhber, Carol J Lane, Mohamad R Azarpazhooh, Elham Salari, Reza Fayazi, et al

Neuropsychiatric Disease and Treatment 2008, 4:227-234

Published Date: 8 February 2008

Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings

Antoni Sicras-Mainar, Ruth Navarro-Artieda, Javier Rejas-Gutiérrez, Milagrosa Blanca-Tamayo

Neuropsychiatric Disease and Treatment 2008, 4:219-226

Published Date: 8 February 2008

Risperidone treatment for ADHD in children and adolescents with bipolar disorder

Joseph Biederman, Paul Hammerness, Robert Doyle, Gagan Joshi, Megan Aleardi, Eric Mick

Neuropsychiatric Disease and Treatment 2008, 4:203-207

Published Date: 8 February 2008

The relationship between early life stress and microstructural integrity of the corpus callosum in a non-clinical population

Robert Paul, Lorrie Henry, Stuart M Grieve, Thomas J Guilmette, Raymond Niaura, et al

Neuropsychiatric Disease and Treatment 2008, 4:193-201

Published Date: 8 February 2008

Resting and reactive frontal brain electrical activity (EEG) among a non-clinical sample of socially anxious adults: Does concurrent depressive mood matter?

Elliott A Beaton, Louis A Schmidt, Andrea R Ashbaugh, Diane L Santesso, Martin M Antony, Randi E McCabe

Neuropsychiatric Disease and Treatment 2008, 4:187-192

Published Date: 8 February 2008

Treatment of adult ADHD: Is current knowledge useful to clinicians?

Terje Torgersen, Bjørn Gjervan, Kirsten Rasmussen

Neuropsychiatric Disease and Treatment 2008, 4:177-186

Published Date: 8 February 2008

Gait analysis in demented subjects: Interests and perspectives

Olivier Beauchet, Gilles Allali, Gilles Berrut, Caroline Hommet, Véronique Dubost, Frédéric Assal

Neuropsychiatric Disease and Treatment 2008, 4:155-160

Published Date: 8 February 2008

Epidemiology and treatment of post-stroke depression

Stefano Paolucci

Neuropsychiatric Disease and Treatment 2008, 4:145-154

Published Date: 8 February 2008

Social anxiety disorder: A review of environmental risk factors

Christina A Brook, Louis A Schmidt

Neuropsychiatric Disease and Treatment 2008, 4:123-143

Published Date: 8 February 2008

Treatment of adults with attention-deficit/hyperactivity disorder

Dusan Kolar, Amanda Keller, Maria Golfinopoulos, Lucy Cumyn, Cassidy Syer, Lily Hechtman

Neuropsychiatric Disease and Treatment 2008, 4:107-121

Published Date: 8 February 2008

Pharmacological management of panic disorder

Carlo Marchesi

Neuropsychiatric Disease and Treatment 2008, 4:93-106

Published Date: 8 February 2008

Depression in Parkinson’s disease: Health risks, etiology, and treatment options

Pasquale G Frisina, Joan C Borod, Nancy S Foldi, Harriet R Tenenbaum

Neuropsychiatric Disease and Treatment 2008, 4:81-91

Published Date: 8 February 2008

A review of ramelteon in the treatment of sleep disorders

David N Neubauer

Neuropsychiatric Disease and Treatment 2008, 4:69-79

Published Date: 8 February 2008

Review of frovatriptan in the treatment of migraine

Leslie Kelman

Neuropsychiatric Disease and Treatment 2008, 4:49-54

Published Date: 8 February 2008

Monotherapy for partial epilepsy: focus on levetiracetam

Antonio Gambardella, Angelo Labate, Eleonora Colosimo, Roberta Ambrosio, Aldo Quattrone

Neuropsychiatric Disease and Treatment 2008, 4:33-38

Published Date: 8 February 2008

Quetiapine monotherapy for bipolar depression

Michael E Thase

Neuropsychiatric Disease and Treatment 2008, 4:21-31

Published Date: 8 February 2008

Rasagiline in treatment of Parkinson’s disease

Lakshmi Nayak, Claire Henchcliffe

Neuropsychiatric Disease and Treatment 2008, 4:11-20

Published Date: 8 February 2008

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features

Angelo Antonini, Giovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, Leonardo Lopiano, et al

Neuropsychiatric Disease and Treatment 2008, 4:1-9

Published Date: 8 February 2008